Pantec Biosolutions out of Liechtenstein has received the European CE mark of approval to take to market the P.L.E.A.S.E. (Painless Laser Epidermal System) transdermal delivery device. The system uses a laser to create micropores in the skin through which high molecular weight drugs are delivered painlessly.
From the product page:
A handheld laser device creates controlled aqueous micropores in the epidermis. Due to the special features of the device the micropores do not reach the dermis, where nerves and blood vessels reside. An intelligent graphical user interface guarantees simple and safe use by the medical personnel or the patient, who can use the device without supervision
A special laser source ablates outer skin tissue painless in a highly controlled and accurate fashion.
- Short pulses practically eliminate thermal damage
- No carbonisation, only fast ablation of skin tissue
- Very accurate skin ablation in 5-10 µm steps
- Variable laser deflection allows flexible formation of pore arrays
Demo video and links below the fold:
Press release: Pantec Biosolutions’ P.L.E.A.S.E. Professional® Receives Marketing Authorisation…
Product page: P.L.E.A.S.E.
Flashbacks: Pantec’s P.L.E.A.S.E.Transdermal Therapeutic System Shows Early Clinical Success; P.L.E.A.S.E. = Painless Laser Epidermal System; P.L.E.A.S.E. To Improve Effectiveness of Drug Patches